Melissa Skala, Morgridge Institute for Research (VIDEO)
Caption
Morgridge Institute for Research investigator Melissa Skala is creating a high-throughput imaging system that works to identify the best possible chemotherapy option before the patient is ever treated. The system can test tumor response to scores of different cancer drug combinations. She accomplishes this by receiving samples of patient tumors and dividing them up into dozens of "organoids," or micro-tumors kept alive in a dish. This process allows Skala to test many different chemotherapy combinations quickly and measure the best cancer-killing response -- helping clinicians predict which treatment option will succeed. Skala's imaging combines both quantity of sampling and sensitivity of measurement, looking at how cell metabolism responds to treatment.
Credit
Morgridge Institute for Research
Usage Restrictions
None
License
Licensed content